Question: In the context of the health of middle-age women, according to Barrett-Connor et al. (2002) and Lindsay, Gallagher, Kleerekoper, and Pickar (2002), identify a true statement about hormone therapy (HT). HT, especially when taken orally, reduces the risk of blood clot and stroke. HT, which begins in early menopause, is associated with increased risk of cardiovascular disease. HT, when started at menopause and continued for at least 5 years, is likely to slow bone loss after menopause. HT is associated with reduced risk of breast cancer among women if estrogen and progestin are used together.